AP NEWS

2-Day Course: Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union (London, United Kingdom - February 28-March 1, 2019) - ResearchAndMarkets.com

January 22, 2019

DUBLIN--(BUSINESS WIRE)--Jan 22, 2019--The “Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union” conference has been added to ResearchAndMarkets.com’s offering.

This interactive course will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation.

The aim of the course is to provide an overview of recent developments in pharmaceutical regulatory affairs in Russia, the Eurasian Union and the CIS.

The course will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation.

The focus will be on practical aspects to assist in developing your regulatory strategy for product approval in these countries and the presentations will give practical hints on the regulatory process where possible.

Attending this programme will:

Give you the full background to the CIS pharmaceutical market Ensure that you understand the full implications of the new regulations which will affect how you do business in the Eurasian Economic Union (EAEU) Help clarify the document requirements and timelines of national procedures and EAEU registration procedures Fully update you on the national regulations in Russia, Belarus, Kazakhstan, Ukraine and other CIS countries

Agenda

Introduction and welcome

Russia - competitive landscape

Current market and projected growth Pharma-2020 and Health-2020 State programmes Pricing and reimbursement Patent and data protection

Clinical trials in Russia and CIS

Russia and CIS in global clinical research Clinical trial requirements Local registrations trials in Russia, CIS and the Eurasian Union

Marketing authorisations in Russia

Regulatory authorities in Russia Key regulations governing the MAA process Registration procedures Application dossier requirements

CIS - regional regulatory overview

CIS pharmaceutical market CIS regional regulation co-operation - the Eurasian Union CIS regulatory barriers for Market Access

Marketing authorisations in CIS

New Eurasian MAA procedure Common regional requirements in CIS

Workshop - CIS Regional Regulatory Strategy

For more information about this conference visit https://www.researchandmarkets.com/research/73hbh7/2day_course?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190122005536/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery

KEYWORD: UNITED KINGDOM EUROPE RUSSIA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/22/2019 08:28 AM/DISC: 01/22/2019 08:28 AM

http://www.businesswire.com/news/home/20190122005536/en

AP RADIO
Update hourly